NOVOPEN Echo Plus Insulin Pen

Product Information

mmol/L) per day, with a reduction in time spent in hyperglycaemia (measured as HbA 1c >10 mmol/L) and level 2 hypoglycaemia (measured as HbA 1c <3. It will allow for more tailored and informed advice on optimisation of glucose levels, with the ultimate goal of improving future outcomes. The deal with Roche will also see similar work, where Novo Nordisk insulin data will be synched with Roche’s diabetes management platforms, such as mySugr and Accu-Chek Smart Pix.

NovoPen®6 or NovoPen Echo® Plus Your guide to using NovoPen®6 or NovoPen Echo® Plus

A leading global healthcare company has launched two smart connected insulin pens in the UK to improve the lives of people living with diabetes.Remote access to this data may also help to support a longer-term transition from in-person to virtual care, during and after the COVID-19 pandemic, which could also help alleviate pressure on health system capacity. The devices have a dose memory display which shows the amount of time that has passed since the last dose, and they can show a person when a dose has been missed. James Ridgeway, 34, is a diabetes specialist nurse (DSN) with type 1 diabetes who has seen both the personal and professional side of using smart insulin pens. Novo Nordisk’s smart connected pens are an example of how technology can support people living with diabetes to gain greater insight into the management of their diabetes, on their journey to becoming experts in their diabetes. There are two smart pens currently available on the NHS, both manufactured by Novo Nordisk: the NovoPen 6® and NovoPen Echo Plus®.

NovoPen® 6 and NovoPen Echo® Plus - Novo Nordisk NovoPen® 6 and NovoPen Echo® Plus - Novo Nordisk

In the meantime, we believe it is important to make NovoPen ® 6 and NovoPen Echo ® Plus available now to those people who wish to use this technology to help manage their diabetes. Novo Nordisk long-term strategy involves enhanced access to the connected pens and offering personalised treatment guidance solutions for people living with diabetes. Everyone with type 1 diabetes, and some people with type 2 diabetes or gestational diabetes, needs to take insulin to help manage their blood glucose levels. We firmly believe that this will help more people realise the full benefit of our innovative medicines and begin to ease the mental burden of diabetes treatment for those individuals.

Now your patients can easily transfer their insulin data from their smart connected insulin pen 1 to the FreeStyle LibreLink app 2 with a quick scan and share their reports with you for more informed patient consultations. Digital health tools such as the smart insulin pen will improve diabetes management by empowering patients with data”, Professor Derek O’Keeffe, Consultant Endocrinologist at University Hospital Galway (UHG), and Professor of Medical Device Technology at the National University of Ireland Galway.

Novo Nordisk two smart insulin pens available on prescription

This data can be uploaded to a compatible app and viewed by people living with diabetes and their healthcare professionals. ie for more information on living with diabetes and NovoPen ® 6 and NovoPen Echo ® Plus smart insulin pens. Eventually, Novo Nordisk plans to integrate its insulin dosing data with Dexcom continuous glucose monitoring (CGM) data.Smart insulin pens can also connect with certain apps that let you keep your insulin dosages and blood glucose data in one place. Roche expects Novo Nordisk insulin pen data will sync to the mySugr app and Accu-Chek SmartPix software. NovoPen ® 6 / NovoPen Echo ® Plus comes with a three-year full guarantee and Novo Nordisk will replace any pens that are faulty within that period. Novo Nordisk will launch the NovoPen 6 and NovoPen Echo Plus in early 2019 in select countries, with an eventual launch in over 50 countries. The company is planning to commercially launch these connected insulin pens in the first quarter of next year across limited markets.